[HTML][HTML] Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study

S Liu, H Luo, Y Wang, LE Cuevas, D Wang, S Ju… - BMC infectious …, 2020 - Springer
Abstract Background Coronavirus Disease-2019 (COVID-19) pandemic has become a
major health event that endangers people health throughout China and the world …

Current epidemiological and clinical features of COVID-19; a global perspective from China

H Tu, S Tu, S Gao, A Shao, J Sheng - The COVID-19 reader, 2020 - taylorfrancis.com
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and represents a potentially fatal disease of great global public …

Clinical and laboratory factors associated with coronavirus disease 2019 (Covid‐19): A systematic review and meta‐analysis

LHN Minh, AAF Abozaid, NX Ha… - Reviews in medical …, 2021 - Wiley Online Library
SARS Coronavirus‐2 is one of the most widespread viruses globally during the 21st century,
whose severity and ability to cause severe pneumonia and death vary. We performed a …

[HTML][HTML] Viral and host factors related to the clinical outcome of COVID-19

X Zhang, Y Tan, Y Ling, G Lu, F Liu, Z Yi, X Jia, M Wu… - Nature, 2020 - nature.com
Abstract In December 2019, coronavirus disease 2019 (COVID-19), which is caused by the
new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was …

[PDF][PDF] The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event

J Sheng, A Shao - 2020 - e-tarjome.com
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and represents a potentially fatal disease of great global public …

Prognostic value of inflammatory biomarkers in patients with severe COVID-19: A single-center retrospective study

G Açıksarı, M Koçak, Y Çağ, LN Altunal… - Biomarker …, 2021 - journals.sagepub.com
Background: The current knowledge about novel coronavirus-2019 (COVID-19) indicates
that the immune system and inflammatory response play a crucial role in the severity and …

Clinical and laboratory factors predicting the prognosis of patients with COVID-19: an analysis of 127 patients in Wuhan, China

T Bai, S Tu, Y Wei, L Xiao, Y Jin, L Zhang… - China (2/26 …, 2020 - papers.ssrn.com
BACKGROUND: Corona virus infective disease 2019 (COVID-19) is an emerging infectious
disease that first outbreak in humans in China in December 2020 and has subsequently …

[HTML][HTML] COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses

J Yi, J Miao, Q Zuo, F Owusu, Q Dong, P Lin… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus2 (SARS-CoV-2), has spread to more than 200 countries and regions, having a …

[HTML][HTML] Demographic, clinical, and laboratory characteristics of patients with COVID-19 during the second and third waves of the pandemic in Egypt

RA Eid, AM Attia, M Hassan, MA Shaker… - Journal of infection and …, 2021 - Elsevier
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel
virus that belongs to the coronaviruses and causes coronavirus disease 2019 (COVID-19) …

[HTML][HTML] Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

J Moutchia, P Pokharel, A Kerri, K McGaw, S Uchai… - PloS one, 2020 - journals.plos.org
Background To date, several clinical laboratory parameters associated with Coronavirus
disease 2019 (COVID-19) severity have been reported. However, these parameters have …